Details
Stereochemistry | ACHIRAL |
Molecular Formula | C26H23F4N9O |
Molecular Weight | 553.5151 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
c1cnc(c(c1C(=O)N2CCC(CC2)N3CC(CC#N)(C3)n4cc(cn4)-c5c-6ccnc6[nH]cn5)F)C(F)(F)F
InChI
InChIKey=KTBSXLIQKWEBRB-UHFFFAOYSA-N
InChI=1S/C26H23F4N9O/c27-20-18(1-7-32-22(20)26(28,29)30)24(40)37-9-3-17(4-10-37)38-13-25(14-38,5-6-31)39-12-16(11-36-39)21-19-2-8-33-23(19)35-15-34-21/h1-2,7-8,11-12,15,17H,3-5,9-10,13-14H2,(H,33,34,35)
Molecular Formula | C26H23F4N9O |
Molecular Weight | 553.5151 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
INCB-039110 (also known as Itacitinib) is an orally bioavailable inhibitor of Janus-associated kinase 1 (JAK1) with potential antineoplastic activity patented by Incyte Corporation for treatment of autoimmune disorders and cancer. Upon oral administration of NCB-039110, this agent selectively inhibits the phosphorylation and activity of JAK1, which may result in inhibition of JAK1-mediated signaling, induction of apoptosis, and reduction of cell proliferation in JAK1-expressing tumor cells. INCB-039110 in combination with nab-paclitaxel plus gemcitabine demonstrated an acceptable safety profile with clinical activity seen in patients with advanced solid tumors including pancreatic cancers. Based on the potential for additive or synergistic effects, NCB-039110 is currently being explored in combination with immunotherapeutic agents including the anti-programmed cell death protein 1 antibody and small molecule inhibitors.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/30115734
300 mg once daily
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Jun 26 09:22:53 UTC 2021
by
admin
on
Sat Jun 26 09:22:53 UTC 2021
|
Record UNII |
19J3781LPM
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
562716
Created by
admin on Sat Jun 26 09:22:53 UTC 2021 , Edited by admin on Sat Jun 26 09:22:53 UTC 2021
|
||
|
NCI_THESAURUS |
C1967
Created by
admin on Sat Jun 26 09:22:53 UTC 2021 , Edited by admin on Sat Jun 26 09:22:53 UTC 2021
|
||
|
NCI_THESAURUS |
C129825
Created by
admin on Sat Jun 26 09:22:53 UTC 2021 , Edited by admin on Sat Jun 26 09:22:53 UTC 2021
|
||
|
EU-Orphan Drug |
EU/3/17/1964
Created by
admin on Sat Jun 26 09:22:53 UTC 2021 , Edited by admin on Sat Jun 26 09:22:53 UTC 2021
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB12154
Created by
admin on Sat Jun 26 09:22:53 UTC 2021 , Edited by admin on Sat Jun 26 09:22:53 UTC 2021
|
PRIMARY | |||
|
1334298-90-6
Created by
admin on Sat Jun 26 09:22:53 UTC 2021 , Edited by admin on Sat Jun 26 09:22:53 UTC 2021
|
PRIMARY | |||
|
53380437
Created by
admin on Sat Jun 26 09:22:53 UTC 2021 , Edited by admin on Sat Jun 26 09:22:53 UTC 2021
|
PRIMARY | |||
|
10313
Created by
admin on Sat Jun 26 09:22:53 UTC 2021 , Edited by admin on Sat Jun 26 09:22:53 UTC 2021
|
PRIMARY | |||
|
CHEMBL3544950
Created by
admin on Sat Jun 26 09:22:53 UTC 2021 , Edited by admin on Sat Jun 26 09:22:53 UTC 2021
|
PRIMARY | |||
|
SUB183665
Created by
admin on Sat Jun 26 09:22:53 UTC 2021 , Edited by admin on Sat Jun 26 09:22:53 UTC 2021
|
PRIMARY | |||
|
C116855
Created by
admin on Sat Jun 26 09:22:53 UTC 2021 , Edited by admin on Sat Jun 26 09:22:53 UTC 2021
|
PRIMARY | |||
|
19J3781LPM
Created by
admin on Sat Jun 26 09:22:53 UTC 2021 , Edited by admin on Sat Jun 26 09:22:53 UTC 2021
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR | |||
|
TARGET -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |